initi coverag market perform high valuat keep us sidelin
initi coverag market perform price target
expect benefit favor demograph age popul
continu drive revenu earn servic shift home-bas care
howev compani high busi concentr low barrier entri premium valuat
keep us sidelin
initi outperform time right
macro sector updat
initi coverag outperform price target
rate reflect strong growth outlook boost demograph trend well
reason valuat ebitda partli reflect stock pullback
sinc august investor concern earn impact new medicar reimburs
model think overdon
upgrad outperform look gold exposur think anglogold
conjunct construct outlook gold link upgrad share
anglogold outperform revis target price
compani solid record deliveri track well toward deliv obuasi year-
add above-averag leverag gold view anglogold one better
larg gold produc exposur rise gold price
report prepar part analyst employ canadian affili bmo nesbitt burn inc
uk affili bmo capit market limit authoris regul financi servic
author uk regist research analyst finra rule
disclosur statement includ analyst certif pleas refer page
downgrad market perform expect pullback ore
rio tinto share enjoy tremend run close high valuat multipl remain compress two us rate cut forecast
could argu upsid multipl expans although like come
howev iron ore rio main driver expect price pull back current inflat level someth like reflect rio share price
downgrad rio tinto market perform maintain target price
altu provid detail five-year roadmap around long-discuss strategi transit altu analyt revenu cloud-bas subscript contract
near-term disrupt margin bit expect vs forecast posit revenu growth remain
think market ultim like financi goalpost call revenu million doubl adj ebitda
margin reflect profit stabl revenu base
organ growth stabl sequenti improv transport steadi growth slight slow financi servic
manag outlin data strategi acceler product develop target step-up long-term organ growth target
view busi mix well-posit cyclic upturn product demand auto altern financi servic slightli
rais estim maintain outperform rate continu see strong long-term stori
rais target price investor event lower ga cost euro ga dynam
market show slight neg overreact yara investor day view like owe yar outperform high investor
expect oper improv higher dividend prospect sale industri nitrogen busi yara announc
though latter may ipo
see upsid nitrogen dynam look strong yar see strong tailwind materi lower european ga cost
rais forecast target price impli ev/ebitda
construct sunris target start
clean teq announc june appoint advisor begin partner process sunris batteri metal complex
process expect complet ahead final invest decis expect construct begin shortli
note updat valuat reduc target price
rais estim higher fee rate
better-than-expect ebitda million versu million estim reflect higher manag fee rate larg due mix shift higher sale
stand-alone fund
increas ebitda estim reflect higher fee rate short term continu forecast bp annual fee pressur longer term aum move
control remain key ebitda growth half sg guidanc million spent agf need demonstr
meet target
attend alder investor breakfast two kol discuss experi treat migrain patient expect eptinezumab would
fit practic
physician enthusiast benefit provid anti-cgrp express linger concern long-term safeti toler
migrain patient volum increas last year physician expand practic
impress eptimezumab posit kol see clear place armamentarium highlight rapid onset sustain benefit
potenti superior complianc differenti attribut
strong televis advertis result off-set soft revenu categori increas opex result slightli lower oper
view unclear whether revenu ebitda growth sustain
plant foundat scalabl model
attend clxt investor day senior manag provid greater detail strateg initi optim suppli chain expand
product offer attract new grower custom creat long-term valu local driven flexibl busi model
maintain newli introduc revenu cash burn work capit outlook howev unusu wet cold spring season upper
mid-west like creat downsid risk acr plant ho soybean acr current plant late june
introduc target nyc analyst day struck optimist tone around growth prospect recent caraustar acquisit bmo remain
cautiou
think biggest risk pp current margin turbo-charg higher price recession-level occ cost industri volum eas
suppli rise margin risk appear firmli skew downsid
maintain under-perform rate key uncertainti trade war china resolut could help rigid industri rip busi
ep exceed consensu higher-than-anticip oper gain favor non-oper item lower interest tax
off-set lower-than-anticip revenu
introduc ep growth outlook growth impli rang howev oper profit growth fell long-
term oper profit target mid-singl digit
recent investor meet increas enthusiasm stock manag team wide consid sector best exemplifi grow
grand canyon univers sector founder
addit orbi educ provid expans servic market one alreadi establish base uniqu focu healthcar
could soon announc new univers partnership crucial growth stori next year
reiter outperform rate one favorit name across coverag univers
offer note review micron recent
review file extract believ important/relev inform
also review risk section materi chang prior period
takeaway ok quarter guidanc slightli red est
headlin slight ep miss read much
manag note continu growth across major product line integr oasi acquisit decemb go well
guidanc incorpor prior consensu prior unoffici guidanc though quarterli cadenc
slightli reduc forward-look estim take account expect slower start earnings-wis year
bmo host fourth annual prescript success healthcar confer nyc
dr scott gottlieb former fda commission invit panel discuss four firm senior health care analyst
panel touch number broad health care issu includ sever topic relev regulatori process relat novel drug develop
specif touch me-too drug class use surrog endpoint drug approv breakthrough therapi design
drug approv timelin approv gene therapi product
commod price updat tone inflect
date commod price either ride macroeconom wave tri keep afloat depend way trade wind
blow pass inflect point global monetari polici howev mani countri loosen bia fundament
start reassert
rate cut tend help commod quickli case preciou metal slowli term industri still face world
industri economi remain nervou impact trade friction
impact china previou fiscal impuls wane next round start near-term demand condit still look mute though
start look better
fill blank
base inform ratio screen qualiti zuq remain best core exposur investor addit low/minimum volatil
canadian defens exposur view supplementari qualiti identifi dividend etf suitabl addit investor look
base return characterist track behaviour hold data dividend etf fill gap qualiti low/minimum volatil
risk/return spectrum address investor concern zuq sector over-alloc technolog commun servic
coordin bmo commod team quarterli commod price/fx forecast updat link updat estim rate target price
univers stock cover bmo global metal mine
made meaning chang sever base metal bulk forecast signific near-term price revis steel copper
aluminum downward iron ore iron ore lump premium upward gold silver forecast broadli unchang near term
lower long-term silver price
downgrad rio tinto market perform outperform upgrad anglogold ashanti outperform market perform rate
target chang detail later report
analysi shown ev/ebitda trade multipl reflect commod exposur near-term cash flow compar asset life
qualiti metric reflect p/nav compon target price
updat target ev/ebitda multipl reflect updat near-term commod outlook
meaning near-term copper forecast bearish revis target multipl reflect outlook
investor day relentless pursuit innov
attend investor day relentless pursuit innov continu drive high single-digit revenu growth
translat double-digit ep
sure franchis pipelin quit full develop product disrupt market reach new adjac drive durabl growth
summar key takeaway mayb import breadth product discuss
frequent investor focu bsx cardiovascular segment good reason much compani reiter outperform
rate bmo top pick
esg oil ga industri
bmo capit market host half-day confer focus esg trend oil ga industri esg grow focu investor strong esg
perform improv sharehold return
oil ga industri success address challeng esg signific advanc technolog industri partnership chang
canadian oil ga well posit becom global leader deliv esg-friendli product global consum view
bmo prescript success healthcar confer specialti pharma wrap-up
host fourth annual healthcar confer june nyc
provid comprehens review key takeaway specialti pharma compani present includ cover compani market
aptx op aqst op bhc market op market op neo market op op scph op slgl op snna op trvi op well
non-cov compani amrn
addit provid key takeaway highli inform keynot discuss dr scott gottlieb commission fda sever import
topic across healthcar includ improv drug develop review process pave way high-valu gener drug price concern
potenti new legisl dim fda could help opioid crisi
initi coverag market perform high
valuat keep us sidelin
bottom line initi coverag market perform
price target expect benefit favor
demograph age popul continu drive
revenu earn servic shift home-bas care howev
compani high busi concentr low barrier entri premium valuat
keep us sidelin
rate reflect overal posit view compani growth outlook off-set
valuat coupl factor specif
busi concentr revenu gener state illinoi
potenti increas competit pressur given low barrier entri core
person care servic pc busi
valuat rel high stock ep
ev/our ebitda latter well rang provid name
cover
see key featur pc attract payer includ lower
labor cost potenti avoid expens inpati hospit admiss re-
rel labor cost averag wage pc provid hh pc aid
per hour well per hour rate higher-skil
rel avoid admiss recent studi report home care aid
contribut declin rate repeat emerg depart ed visit
declin rate re-hospit yield save per
think payer may inclin add pc medicar advantag
medicaid manag product design time background
medicar traditional/ma histor cover
meanwhil maintain flexibl capit structur hold minim debt
think compani would will increas leverag larger
opportun increas market penetr exist market expand
geograph presenc key target market
remain sidelin reflect lack visibl
may benefit expand supplement
benefit reimburs program
aduss current person care servic busi
natur fit non-primarili health relat activ
reserv expect payer
take measur approach adopt
total liabil share equiti
price object impli ev/ebitda
premium five- ten-year price-to-earnings averag
respect think premium warrant
potenti govern busi opportun longer-
term howev lack visibl make us think new
busi recogn next month
per share upsid price repres
ebitda upsid scenario base faster earn
growth increment well adopt
plan impli current ebitda growth
approxim ebitda modestli
concentr may appeal payer oper
nation basi oper state signific
concentr three state il ny nm drive less
upsid potenti opportun near term
usd
addu homecar corp engag provis in-hom
person care servic three segment person
provid non-med assist activ
daili live hospic includ physic emot care
termin ill patient health offer servic
individu may requir assist ill
initi outperform time right
bottom line initi coverag outperform
price target rate reflect strong growth outlook
boost demograph trend well reason valuat
ebitda partli reflect stock pullback sinc august investor
concern earn impact new medicar reimburs model
think overdon
nation largest provid inpati rehab irf drive
total revenu home health hh make remaind
heavili weight older popul come exposur medicar
reimburs risk investor keenli awar howev also mean
cusp acceler volum tailwind babi boomer reach age peak
util year rel insul neg payer mix shift impact
provid notabl hospit babi boomer age lower reimburs
medicar alreadi
meanwhil see time reimburs chang favor sinc
fulli overli factor investor model street
consensu next big chang probabl year away
regard specif impact reimburs chang highlight
irf transit function independ measur fim expect
ebitda headwind million believ off-set oper
product increment volum
million reflect million histor patient mix million
assum behavior chang cut confid off-set
patient mix headwind among factor data evolv
use new model
final highlight conserv capit structur give flexibl
pursu accret acquisit complement exist and/or develop new
geograph market well acceler top- bottom-lin growth
annual impli current model
construct view long-term
industri outlook see well-posit
achiev object acceler revenu growth
drive margin expans demograph
emphasi clinic collabor
vertic integr well scale advantag
deliv high-qual care lower-cost
total liabil share equiti
target price base ebitda
current premium five-year
averag reflect posit five-year outlook
acceler popul growth key age cohort
year current market irf hh
compar nation averag exceed
growth market prior eight-year period
per share upsid price repres
ebitda five-year averag valuat
believ premium five-year averag
warrant given solid ebitda margin free cash
flow gener moreov acceler popul
key age cohort posit see above-averag
growth forese futur
ebitda pariti compani five-
trade level event new reimburs
model greater impact revenu earn
impli consensu model
usd
earn medicar irf hh final rule
leader inpati rehabilit
facil lead oper home health agenc
oper state puerto rico recent
compani chang name prior
healthsouth complet implement
encompass
bottom line bmo host fourth annual prescript success healthcar
confer nyc dr scott gottlieb former fda commission invit panel
discuss four firm senior health care analyst panel touch
number broad health care issu includ sever topic relev regulatori
process relat novel drug develop specif touch me-
drug class use surrog endpoint drug approv
breakthrough therapi design drug approv timelin approv gene
multipl me-too drug approv recent meet american
associ cancer research last april padzur head oncolog
divis fda voic felt quit vehement critic industri
devot time resourc toward develop multipl
agent target immunocheckpoint pathway seven pharma compani
approv inhibitor dr padzur stress patient
preciou resourc industri collabor develop
import drug class dr gottlieb respect disagre view
indic develop agent especi larg market
healthi industri stress howev industri collabor
enough spear-head variou head
surrog endpoint use drug approv develop sever surrog
endpoint includ minim residu diseas metastasis-fre surviv occur
dr gottlieb watch view success indic
biolog mani diseas becom well understood rapid approv
justifi mani intuit design agent proven quit
effect problem realli commerci regulatori cite incid
medicaid one particular state deni coverag accelerated-
approv drug base perceiv lack proven efficaci and/or safeti howev
breakthrough therapi design breakthrough therapi design came
congress push expedit market approv drug unmet
medic need sinc enact mani drug receiv design
may dilut valu distinct rather overus
agenc dr gottlieb believ qualiti drug develop improv
breakthrough therapi design achiev intend effect
gene therapi approv dr gottlieb believ acceler approv process
quit appropri mani gene therapi applic given dramat
effect seen rel small patient group also provid fda easi flexibl
remov product market legally-bind confirmatori studi uncov
safeti efficaci issu larger popul furthermor given complex
gene therapi recruit qualifi peopl fda review portion
applic constitut approv process challeng given pauciti
expert space retent also challeng expert often hire away
compani develop agent
 individu compani commentari
bottom line coordin bmo commod team quarterli commod
price/fx forecast updat link updat estim rate target price
univers stock cover bmo global metal mine
made meaning chang sever base metal bulk forecast
signific near-term price revis steel copper aluminum downward
iron ore iron ore lump premium upward gold silver forecast
broadli unchang near term lower long-term silver price
downgrad rio tinto market perform
outperform upgrad anglogold ashanti outperform market perform
rate target chang detail later report
industri metals/bulk equiti rel prefer shift base metal
bulk go bulk commod perform well ytd go forward
see higher risk downsid bulk price hand base metal
expect recov second half year investor posit
defens ahead june summit fear us-china led trade
war would impact global econom growth defens posit favour
base metal produc saw rel weak share price perform
optimist go forward see increas probabl
quantit eas argument support base metal price
improv supply-demand fundament also underpin bullish base metal
outlook howev note anticip recoveri degre alreadi
reflect equiti price result near-term downward lower
target price mani base metal produc coverag univers also
downgrad rio tinto market perform outperform prefer equiti
alphabet valu anglo american valu graftech valu
lundin defens growth teck resourc valu warrior
preciou metal equiti halfway year equiti perform
mostli posit tsx global gold index ytd equiti
support rise gold price ytd silver-expos compani
challeng metal ytd diverg
two preciou metal push gold silver ratio record level highlight
commod price updat link near-term gold/silv price chang fairli
modest gold silver lower long-term silver
price result nav/eps/cfp chang detail
tabl back report conjunct commod price updat
preciou metal team migrat set price target cfp
multipl prefer equiti alamo gold pretium resourc rel
valu wesdom upcom catalyst agnico eagl fortuna silver growth
lundin gold continent gold develop exposur
detail breakdown impact commod
price fx chang earn valuat target
price compani subsector
bottom line analysi shown ev/ebitda trade multipl
reflect commod exposur near-term cash flow compar asset
life qualiti metric reflect p/nav compon target price
updat target ev/ebitda multipl reflect updat near-term
commod outlook meaning near-term copper forecast bearish
revis target multipl reflect outlook
ev/ebitda multipl follow cyclic path histor data equiti
coverag univers exhibit shown p/nav trade multipl higher
larger compani wherea ev/ebitda trade multipl correl
compani size view ev/ebitda trade multipl reflect
commod exposur near-term cash flow
updat target multipl reflect current near-term commod
outlook near-term outlook turn bearish particularli copper
forecast averag price fallen pleas see commod price updat
tone inflect full overview commod price chang
signific chang target multipl copper extens copper-
produc equiti summar exhibit rais ev/ebitda multipl
previous approach upper end histor ev/ebitda
trade rang pure-play copper produc shown exhibit approxim
updat target price reflect chang commod
price target multipl chang summar exhibit
signific chang target price first quantum fallen
target price lundin mine fallen per share
rate rel order prefer unchang
bmo prescript success healthcar
bottom line host fourth annual healthcar confer june nyc
provid comprehens review key takeaway specialti pharma
compani present includ cover compani market aptx
op scph op slgl op snna op trvi op well non-cov
compani amrn addit provid key takeaway highli
inform keynot discuss dr scott gottlieb commission fda
sever import topic across healthcar includ improv drug develop
review process pave way high-valu gener drug price concern
potenti new legisl dim fda could help opioid crisi
rx success sentiment spec pharma poor signific
under-perform ytd vs larg driven broad concern
gener price-fix litig opioid litig challeng new
launch drug price especi head new elect cycl leverage/
financ overhang howev bit lift announc abbv/agn
deal highlight could anoth round consolid biopharma lot
depress valuat compani struggl improv growth profil
notabl spec pharma compani confer present
bullish outlook respect busi believ paint broad
neg brush across sector result numer disloc stock
rel fundament valu year better perform stock
relat pipelin success key data readout anticip similar
formula remaind year one main goal confer
explor sever key theme help offer guidanc success invest
sector includ underappreci pipelin gaug new launch better durabl
key asset improv balanc sheet appetit provid top
increment take-away confer cover compani
market untap pipelin complex gener inject inhal insulin
product aptx op optimist path forward chronic pain base
total data aqst op disloc stock given suboxon brand/ag maintain
good share underappreci pipelin bhc market confid growth
target support strength salix new launch op pleas
perform zilretta confid guidanc market make stride
turnaround new launch cost cut debt reduct op
uncertainti could lift next month acthar develop gener spin
key readout neo market commerci realign season help
acceler profit rx growth op xhanc momentum continu
sever key driver support acceler growth op optimist
mdd outcom signific prepar zulresso launch
underappreci early-stag pipelin scph op track refil furoscix
optimist anoth pk studi necessari slgl op confid
immin epsolay data follow data snna op track
start interim statist reassess trvi op
enrol prism trial progress well interim reassess earli
construct sunris target start
bottom line clean teq announc june appoint advisor
begin partner process sunris batteri metal complex
process expect complet ahead final invest decis
expect construct begin shortli note
updat valuat reduc target price
advantag partnership find strateg partner would
contribut clean teq equiti compon capit cost also potenti offer
oper metal market assist sunris project
updat nav-bas target
maintain outperform rate discuss updat provid
largest contributor updat reduc p/nav
target-set multipl reflect lower market interest batteri
metal gener cobalt specif lower multipl also reflect
potenti portion dilut ad partner contribut financ
sunris project
notabl valuat assumpt chang incorpor
report construct start date push back one year
earli line june press releas
continu model sunris basi definit feasibl base case
nickel/cobalt product profil adjust latest resourc updat
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
aud
clean teq advanc sunris nickel/
cobalt deposit toward develop deliv
product profil expect clean teq continu
gain market attent one sizabl
advanc new cobalt develop outsid africa
target price base multipl
line peer develop approach
feasibl yet financ
upsid scenario base inclus scandium
circuit product referenc resourc
downsid scenario base increas
capital-expenditure opex
cad
clean teq advanc sunris nickel-cobalt
deposit nsw australia toward develop decis
complet definit feasibl studi
sunris project one sizabl advanc cobalt
develop project outsid africa
upgrad outperform look gold
bottom line conjunct construct outlook gold link
upgrad share anglogold outperform revis target price
compani solid record deliveri track well toward deliv obuasi
year-end add above-averag leverag gold view
anglogold one better larg gold produc exposur rise gold price
look larg gold produc coverag anglogold come long way
compani ration oper base paid
debt focus execut
look compani today anglogold modest debt level third-quartil
stabl cost structur begun reinvest busi australia
recent ghana redevelop obuasi view
attribut make anglogold lower-risk invest above-averag leverag
oper financi gold price
look valuat prior commod updat anglogold trade
vs peer cfp vs peer gold
price leverag come play use spot gold versu long-
term price anglogold trade distinct discount peer
versu peer cfp vs peer base
revis commod outlook anglogold trade
let look risk bit close investor view anglogold
remain over-expos south africa howev sever round
divestitur compani decreas product exposur south africa
recent compani announc plan divest south africa
believ lead de-risk next month
given construct outlook gold outlin
commod updat link upgrad share anglogold outperform
revis target price target price base
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
compani embark next stage
ration view share au remain
catalyst rich cours earli
support improv outlook better mine-lif
au trade npv estim bmo metal
price assumpt vs larg gold produc averag
target price reflect
cfp bmo metal price assumpt
upsid scenario base
cfp bmo metal price assumpt
downsid scenario base
cfp bmo metal price assumpt
usd
deliveri obuasi budget time new
anglogold ashanti gold mine compani global
portfolio includ oper south africa drc ghana
mali tanzania australia argentina brazil
downgrad market perform expect
pullback ore
bottom line rio tinto share enjoy tremend run close
year high valuat multipl remain compress two us rate cut forecast
could argu upsid multipl expans although
like come howev iron ore rio main driver expect price
pull back current inflat level someth like reflect rio
share price downgrad rio tinto market perform maintain
target price
iron ore pullback well-docu suppli challeng stronger-than-expect
chines steel product lift iron ore price inflat level rio
tinto bhp shipment track meet revis guidanc vale restart
suspend product estim iron ore price well level need
incentivis swing product need balanc market
combin season upturn iron ore deliveri expect eas
pressur caus benchmark index pull back today
year end
pullback expect weigh rio tinto share price whilst think
rio tinto fulli price current spot iron ore price iron ore account
rio tinto ebitda everi move iron ore equat
move rio ebitda move ebitda think pull back
iron ore like express rio tinto share price
downgrad market perform reflect view downgrad rio
tinto market perform keep target price whilst downgrad
rio tinto continu prefer bhp market term valuat
multipl structur busi gulf geopolit tension drive break-out
oil ga price howev bhp would go-to name diversifi peer
anglo american op remain top pick valuat discount
group potenti drive perform improv
offer best copper option growth group state quarterli
updat switch prefer bulk commod base metal
report prepar analyst employ bmo capit market limit authoris
regul financi conduct author uk analyst regist
research analyst finra rule
rate rio tinto market perform whilst view rio
tinto amongst attract peer group
term valuat multipl corpor strategi
like off-set near term downsid
risk price iron ore signific driver
earn
estim rio tinto npv per share
rio tinto earn highli lever price iron
ore product earn came
iron ore busi increas bmo iron ore
price would impli price assum similar
target multipl current p/npv
rio tinto earn highli lever price iron
ore product earn came
iron ore busi decreas bmo iron ore
price would impli price per share assum
similar target multipl current p/npv
gbp
macro consider commod price movement
like signific near-term driver rio
tinto although company-level advantag see
close valuat gap bhp medium-
rio tinto lead diversifi metal mine
compani compani world second-largest
produc iron ore fifth-largest copper produc
second-largest aluminum produc also world
largest produc bauxit titanium dioxid slag
net chang borrow
fund return sharehold
net chang
bmo new commod price forecast
brief analysi major base preciou
bulk commod
commod price updat tone inflect
bottom line date commod price either ride
macroeconom wave tri keep afloat depend way trade
wind blow pass inflect point global monetari polici
howev mani countri loosen bia fundament
start reassert rate cut tend help commod quickli case preciou
metal slowli term industri still face world
industri economi remain nervou impact trade friction impact
china previou fiscal impuls wane next round start near-
term demand condit still look mute though start look better
tactic preciou bia given current macroeconom condit
believ gold move new rang much recent monetari
polici shift price quickli believ asset alloc flow continu
offer near-term support world overal asset manag
rise environ risk-on mode help scenario gold silver
offer near-term torqu precious-posit environ think
gold silver ratio obsolet harm long-term posit
posit platinum time past two year palladium
may struggl maintain current price premium remain fundament tight
well posit auto stimulu china beyond
industri metal may wait world becom passiv concern
around industri economi particularli season weak northern
hemispher summer underli fundament better might
expect ytd see copper sell-off unjustifi would expect higher price
year-end skew aluminium remain upsid contrast see
expect nickel market still optimist given rampant suppli growth
ore much special situat present given extent suppli
disrupt howev given iron ore also effici market also view
discuss isnt whether new normal rather long
maintain current level clear skew risk around current price
downsid build port inventori like catalyst iron ore
still provid good margin incumb produc prefer cycl
exposur met coal india alreadi domin buyer meanwhil feel
though time trade cost curv manganes ore thermal
coal end
vast major long-run price unalt howev
lower lead forecast silver forecast increas
molybdenum tin price forecast respect
detail research team equiti view back updat commod
bottom line ep exceed consensu higher-than-
anticip oper gain favor non-oper item lower interest tax
off-set lower-than-anticip revenu introduc ep growth
outlook growth impli rang howev oper profit
growth fell long-term oper profit target mid-singl digit
despit view begun establish strateg flywheel toward
sustain growth base busi growth may self-fund requir
invest oper profit guidanc fell short long-term algorithm
despit moder inflat inclus higher growth buffalo
turnaround yogurt restor growth soup dough
busi aforement challeng resolv new issu emerg
recent includ shift retail inventori level weak us snack franc
higher promot expens
despit concern long-term growth algorithm fulli lost faith
abil surpris upsid re-establish long-term growth rate
light portfolio strategi cost opportun growth initi fact
continu envis framework giss busi gener msd oper
return growth yogurt last year larg regain lost
greek distribut replac higher turnov product includ oui
distribut opportun ice cream snack bar well on-going cost
continu expans strateg revenu manag initi particularli
e-commerc channel
greater sku product follow earli distribut ramp fdm
low current sku product third product lead brand suggest
continu gener solid growth given robust store
growth oldest fdm custom
notwithstand view taken right
strateg measur return busi sustain
growth remain sidelin may
anoth invest year long-term growth
target may question
good sold
total liabil equiti
target price impli underli ep
upsid scenario would reach prior
manag aggress target oi margin
ep scenario give histor
normal earn multipl given difficult
oper environ food compani increas
reflect greater-than-expect dilut
buffalo acquisit and/or execut miscu addit
system weak food oper environ
scenario oi margin compress well
inabl recov price key categori cereal
weak sustain assign multipl
usd
cereal categori declin moder
anyth near flat would view posit
price return yogurt categori sale show
sustain revers neg growth trend
 overal price begin declin
driven growth pl retail demand lower
price respons amazon expans groceri
gener mill world sixth-largest food compani
produc market packag consum food
includ ready-to-eat cereal yogurt ice cream frozen
bake mix frozen veget product
bottom line recent investor meet increas enthusiasm stock
manag team wide consid sector best exemplifi
grow grand canyon univers sector founder addit orbi
educ provid expans servic market one alreadi
establish base uniqu focu healthcar could soon announc new
univers partnership crucial growth stori next year
reiter outperform rate one favorit name across coverag univers
recent investor meet bolster enthusiasm stock manag
continu prove wide believ sector best deep
knowledg competit environ potenti growth opportun
well expertis oper profit grow univers januari
addit orbi educ provid near- intermediate-term growth
driver could prove import new univers partnership
view nevertheless provid ad diversif beyond grand canyon
grand canyon univers still core focu given size estim
student fall profit cash flow gener
provid servic school addit continu grow school
face regulatori competit pressur solidifi manag team
street cred view
addit orbi educ may underappreci acquisit surpris
mani given lope strong organ growth track record howev believ orbi
ad faster grow compon stori revenu growth
compound-annual-growth-rate expect one could also prove profit
recently-ad program matur unit sole focu healthcar undergradu
program direct work healthcar provid differenti orbi
opm view
potenti new univers partnership help crucial still believ
announc first univers partnership within next day
help show demand lope servic univers
believ larg profit driver next year given start-
cost involv
reiter outperform rate one favorit name across
valu reduc sector risk nevertheless core
clientgrand canyon universitycontinu steadi
growth path student appreci school valu
ep share os
provis benefit inc tax
chang work capit
short long-term debt
growth margin data
averag price-to-earnings ev/ebitda discount cash flow base
forward-look estim
upsid assum multipl expans forward-look
ep estim higher
downsid assum multipl contract forward-
look ep estim lower
usd
migrat manag servic provid enrol trend
inc comprehens region
accredit univers offer approxim
graduat undergradu degre program
certif across eight colleg on-line
bottom line altu provid detail five-year roadmap around long-discuss
strategi transit altu analyt revenu cloud-bas subscript contract
near-term disrupt margin bit expect
revenu base think market ultim like financi goalpost
call revenu million doubl adj ebitda
margin reflect profit stabl revenu base
altu host investor call provid roadmap around strategi
transit altu analyt aa consolid revenu revenu
recur drive cloud argu enterpris ae subscript sale
favour on-premis strategi discuss manag mani
month call provid colour around execut financi
ultim next step argu softwar evolut migrat cloud
key custom benefit includ argu cloud leverag ae exist power
calc engin preserv mani year custom model establish global data
standard larg custom reduc infrastructur cost lay groundwork
next frontier data monet strategi
transit subscript expect revenu growth
like remain intact support aa exist recur revenu base
target increas disrupt expect mitig
near-term hybrid sell model exist user eventu convers
cloud-onli see transit chart herein altu goal migrat vast major
ae on-premis custom cloud next three year
near-term margin disrupt expect quick ramp see guidanc
chart herein posit aa revenu guidanc growth line
forecast adj ebitda margin expect bit
estim beyond altu forecast ramp revenu
ebitda margin subscript revenu
stack leverag previou develop expens
move valuat year think appropri captur
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
rate altu outperform momentum altu
analyt continu strong compani
leverag technolog product offer robust
global data analyt platform along
independ global commerci real estat owner
need expect acceler
chang non-cash wc
cfo w/c
free dividend
dividend
dividend adj ni
total liabil share equiti
target price base sum-of-the-part
analysi impli target multipl ev/
ebitda believ target valuat multipl could
potenti move higher time argu data
analytics-intens platform becom meaning
contributor ebitda
posit view stock could lead forecast
ebitda growth target multipl
ev/ebitda impli share price
bear case forecast ebitda growth
multipl ev/ebitda impli
share price
cad
growth altu analyt custom base transform
acquisit new entrant industri could
drive increment demand altu product expans
altu product serv new adjac market
increas demand data data analyt growth
geomat resurg oil ga sector
altu group lead provid independ advisori
servic softwar data solut global
commerci real estat industri oper north
america europ asia pacif three busi
segment altu analyt commerci estat
servic properti tax valuat advisori
bottom line introduc target nyc analyst day struck
optimist tone around growth prospect recent caraustar acquisit
remain cautiou think biggest risk pp current margin
turbo-charg higher price recession-level occ cost industri volum
eas suppli rise margin risk appear firmli skew downsid
maintain under-perform rate key uncertainti trade war china
nyc analyst day today introduc target
ebitda adj also highlight caraustar integr
progress well expect achiev minimum synergi end
yr also explor strateg option caraustar consum pkg busi
volum remain pressur three busi corrchoic sheet
busi vol feb-apr low/mid-singl digit may similar
june flat y/i containerboard vol recent
acquir caraustar busi vol fell volum remain similar pace
may june rigid industri packag rip trade war china
slow global industri economi pressur volum north america
remain concern financi target optimist especi
paper packag pp point ebitda target
pp compar legaci run-
rate ebitda caraustar record year pp -- boost best
world combin rise containerboard price fall occ cost
target assum occ rang containerboard price current level
assumpt look optimist us particularli industri fundament
weaken think risk clearli skew downsid continu make
noteworthi progress flexibl packag howev ebitda margin
room improv make chang
estim note
concern lever
caraustar global economi show
sign slow perform rip busi
largest busi lacklust volum
busi neg margin risk
skew downsid paper
chang work capit
target price base ev/ebitda multipl use
ebitda also includ after-tax pension liabil
well estim valu timberland target
price base ebitda
assum ebitda multipl get
upsid scenario price
assum ebitda multipl get
downsid scenario price
usd
global industri demand demand/pr paper
packag oper execut
greif lead global produc industri packag
product includ metal plastic paperboard barrel
drum well intermedi bulk contain larg
sewn bulk sack compani modest-s posit
containerboard greif also own acr timberland
 greif recent acquir caraustar
bmo capit market canadian associ
petroleum produc capp host half-day
confer focus esg trend canadian
oil ga industri confer featur four
panel provid perspect investor oil sand
compani canadian expert panel
esg oil ga industri
bottom line bmo capit market host half-day confer focus esg
trend oil ga industri esg grow focu investor strong esg
perform improv sharehold return oil ga industri success
address challeng esg signific advanc technolog industri
partnership chang corpor polici canadian oil ga well posit
becom global leader deliv esg-friendli product global consum
view
investor perspect investor increasingli incorpor analysi esg
risk invest process compani engag import factor
provid opportun influenc chang compani polici therebi
allow investor invest compani face materi esg issu believ
mani investor view esg integr part fiduciari duti believ
good mean sacrif return contrari strong esg
perform actual improv financi result sharehold return
multi-facet innov oil sand oil sand session focus
sector innov effort capabl garner insight three lead
expert canadian natur resourc imperi oil suncor key messag
compani sector gone materi transform
address grow sustain risk focu innov term
technolog progress social/govern polici becom core drive
principl grow industri collabor materi expand sector
capabl deliv step-chang environment improv sever emerg
technolog highlight potenti revers neg imag
sector world stage
 produc perspect corpor cultur lead strong esg
metric above-averag sharehold return key discuss point high
perform cultur motiv engag employe well align
incent structur owner-oper mindset factor drive
busi success board govern anoth topic discuss divers
divers opinion sought qualiti strengthen board
abil respond chang also help set strategi compani
recommend sustain financ final report expert panel
sustain financ provid road map canadian investor compani
report recommend canadian feder govern develop clear standard
investor well promot canadian oil ga industri capabl
suppli global market cleaner respons produc product
bottom line strong televis advertis result off-set soft
revenu categori increas opex result slightli lower oper
margin view unclear whether revenu ebitda growth sustain
consolid result coruss result end may mix
consolid revenu increas million consensu million
adjust ebitda flat million consensu million adjust ep
vs consensu last year report million vs
million last year overal oper margin compress y/i due increas
variabl stock-bas compens tough expens comp
televis revenu mix advertis revenu subscrib
revenu tv ad revenu increas vs last year attribut
greater price flexibl traction ad-tech advertis re-calibr
media mix budget look ahead manag expect tv advertis growth
remain posit temper pace subscrib revenu declin
ex tln divestitur merchandis distribut revenu
y/i basi
radio remain soft revenu declin million adjust ebitda
lower million line consensu revenu declin
continu reflect lower demand auto largest contributor declin
region challeng alberta certain ontario market
corpor balanc sheet coru achiev de-lever target net
debt/ebitda remind result coru announc
dividend cut annual paid
quarterli instead monthli cash save million impli
de-lever per year absent recess manag see immin
 opportun guid focu de-lever balanc sheet and/or
forecast forecast rel flat ebitda growth target
reflect ebitda
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
coru rate market perform base rel
growth profil cash flow gener
televis advertis subscrib fee
believ compani face structur regulatori
headwind medium long term
target price reflect ebitda estim
discount histor trade rang due
assum multipl expans return sustain
revenu growth advertis own content
assum multipl contract due acceler
advertis declin cord-cut
cad
return sustain revenu growth advertis
own content licens deal
coru entertain largest non-vert integr
televis broadcast canada coru own portfolio
radio station across countri includ
station cluster toronto ottawa sever major
famili women brand ytv treehous
bottom line offer note review micron recent
review file extract believ important/relev
inform also review risk section materi chang
prior chang mostli concentr risk section relat trade
tension huawei
addit risk includ risk around inventori obsolesc respect
 ban sale huawei ban sale huawei china
huawei custom trail nine month
compani balanc sheet inventori increas q/q million raw
materi decreas q/q million wip increas q/q billion
finish good increas q/q million
subsequ end third quarter micron final sale
fabric facil singapor expect recogn gain
approxim million fourth quarter
rate mu share outperform believ
close cyclic trough stock see
attract risk-reward profil share
base target price micron normal earn
assign slightli lower stock five-year
assum cyclic peak closer one
wit
assum industri continu go deeper cyclic
downturn stock trade price-to-book multipl
market factor potenti neg given
usd
evid cut competitor
manufactur plan convers evid
widen deterior fundament
inc lead manufactur
memori technolog includ dram nand flash
flash basi solid-st drive modul
multi-chip packag system solut
compani product sold comput consum
enterpris storag network mobil embed
bottom line attend alder investor breakfast two kol discuss
experi treat migrain patient expect eptinezumab
would fit practic physician enthusiast benefit
provid anti-cgrp express linger concern long-term safeti
toler migrain patient volum increas last year
physician expand practic impress eptimezumab posit
kol see clear place armamentarium highlight rapid onset
sustain benefit potenti superior complianc differenti attribut
market high unmet need kol agreement demand
migrain treatment high averag wait six month patient mix includ new
patient return patient previous laps care
group look new treatment option notabl headach specialist treat
sever patient seen chronic migrain fail
provid superior faster onset benefit exist oral treatment
better patient toler kol prefer combin botox anti-cgrp
press payor pick one saw patient choos anti-cgrp due influx
patient driven anti-cgrp approv kol expand capac hire
headach specialist expand network treatment site nyu branch
hire brooklyn long island servic iv capabl
still room improv despit improv efficaci oral treatment
patient treat anti-cgrp still inadequ respons creep toler
issu constip mostli aimovig inject skin reaction hair loss
mood chang also concern physician also concern long-term
safeti especi children adolesc pregnant women lastli current anti-
cgrp self-administ inject mani patient overcom self-
inject posit eptinezumab
enthusiast eptinezumab kol enthusiast eptinezumab
efficaci safeti profil particular physician highlight day impact
eptinezumab sustain benefit time allow quickli discern
patient respond treatment quarterli iv infus schedul compar
botox physician saw better complianc self-administ inject iv
infus capabl deterr sinc kol infus capabl on-sit
view potenti revenu sourc practic
outperform rate base belief
lead drug eptinezumab well-posit achiev
blockbust statu migrain prevent market
potenti achiev unadjust peak
sale alon
total liabil share equiti
target price base dcf alder
expect cash flow discount
competit lead rapid launch
higher peak market share chronic
vs base case see potenti
upsid row territori introduct
eptinezumab show inferior competit profil upon
launch lead slower uptak lower market
usd
anticip launch eptinezumab
alder clinical-stag biotech compani focus
develop commerci antibodi
compani lead drug eptinezumab phase trial
rais target price investor event lower
ga cost euro ga dynam
bottom line market show slight neg overreact yara investor day
view like owe yar outperform high investor expect
oper improv higher dividend prospect sale
industri nitrogen busi yara announc though latter may
ipo see upsid nitrogen dynam look strong yar see strong
tailwind materi lower european ga cost rais forecast
target price impli ev/ebitda
rais ebitda estim lower european ga cost
though could lot higher use spot ga obvious
aggress base case assumpt
european ga vs spot ga
ga cost repres ebitda
increas op improv target though longer time period yara expect
achiev save vs base price
base line price first compani expect squeez
exist product ammonia finish product lower ammonia
energi usag top previous announc growth project second yar see flat
fix cost contribut improv total save
third yara model improv work capit effici achiev yara
expect implement cost
target base case though yar achiev recent
year yara expect increment improv program growth
project plu upsid commod price return mid-cycl level
black sea urea vs spot assum european ga
yar consid sell industri nitrogen total ebitda
interestingli instead pursu sale busi would
expect compani consid ipo unit decis expect
earli yara expect retain sizabl ownership post ipo assum
ipo would complet similar multipl yar core valuat
yara target dividend pay-out ratio vs previous
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
nok
expect yara rel outperform versu
fertil peer consid valuat larg
potenti step-up earn oper
improv expans program lower
european ga cost expect balanc
higher bmo fertil price deck estim
valuat lower ev/ebitda multipl
lower bmo fertil price deck estim
valuat ev/ebitda multipl
nok
normal season nitrogen ralli magnitud spread
chines anthracite/therm coal versu european ga
cost abil execut cost cut improv
expans initi potenti ipo industri nitrogen
yara one world largest produc ammonia
nitrat fertil blend yara nitrogen
product europ compani also produc
via plant jv trinidad qatar libya
russia brazil canada australia yara also
increas brazilian upstream/downstream presenc
sale market
end year
investor day relentless pursuit
bottom line attend investor day relentless
pursuit innov continu drive high single-digit revenu growth
translat double-digit ep sure franchis pipelin quit full
develop product disrupt market reach new adjac
drive durabl growth summar key takeaway mayb
import breadth product discuss frequent investor focu
bsx cardiovascular segment good reason much
compani reiter outperform rate bmo top pick
manag financi guidanc organ revenu compound-annual-growth-rate
maintain midpoint guidanc oper margin
expans driven mainli sg improv double-digit earn
growth larg use tuck-in acquisit note
guidanc includ btg acquisit expect close
urolog pelvic health expand market leadership market
forecast expand continu adopt lithuvu single-
use scope stone treatment rezum treatment bph expans
spaceoar hydrogel new indic pancreat breast thyroid cancer
endoscopi franchis particip market forecast reach
array single-us scope includ upcom launch exalt
duodenoscop spyglass discov choledochoscop
rhythm manag market compound-annual-growth-rate
highlight develop modular system trial empow
leadless pacemak expect begin faster grow ep
segment focu advanc map two shot single-shot
technolog ce mark expect polarx lumin pain
therapi continu attract market growth
slowdown appear transitori new clinic data
refresh product cycl next gener system expect follow
virgin back pdn indic help revit growth market
peripher intervent market increas annual
deliv market growth intervent oncolog includ expand
indic btg theraspher system liver metastat colorect cancer
drug-elut devic includ eluvia stent ranger balloon fda approv
saval btk balloon ww launch paclitaxel panel manag
expect market recov similarli coronari de market recov
intervent cardiolog includ robust structur heart portfolio
watchman laa devic market expect increas
aortic mitral transcathet valv market expect reach
lotu edg full launch intermedi risk approv
milliped ef expect begin
rais estim higher fee rate
bottom line better-than-expect ebitda million versu million
estim reflect higher manag fee rate larg due mix shift higher
sale stand-alone fund increas ebitda estim reflect higher fee rate
short term continu forecast bp annual fee pressur longer term
aum move toward lower-fe funds/etf control remain key ebitda growth
half sg guidanc million spent agf
need demonstr meet target
ebitda million ep million
bp versu bp estim exclud altern aum million
ep impact slightli higher contribut whl million ep
partli off-set higher sg million ep manag expect fee rate
continu increas slightli short term conserv forecast flat fee
rate rest versu previou estim bp per quarter declin
guided-to bp annual fee pressur
retail net redempt million versu net redempt estim
million adjust net sale million reflect weaker industri
flow overal three-year fund perform aum median remain
target sub-advisori redempt billion expect
result million annual revenu impact
agf commit purchas million worth whl share maintain
ownership stake anticip certain dilut event prior expect ipo
forward earn averag forward trade multipl compar agf
interest whl could valu million versu million carri valu
increas ebitda million million ebitda
million million reflect higher manag fee rate addit
manag fee agf altern platform million annual expect
begin partli off-set billion aum loss impact
target repres forward ebitda ebitda reflect
agf averag past five year continu secular trend margin
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
agf retail gross sale net flow improv
increas confid compani ultim
return sustain net sale longer term
still believ agf face challeng chang
environ mutual fund put pressur fee
increas cost squeez margin control
remain key earn growth
manag advisori admin
amort dsc
agf trade trail ev/ebitda excl dsc paid
versu long-term averag five-year averag
target price repres forward
upsid case would see higher aum growth driven
higher-than-forecast annual market appreci
faster-than-expect return posit flow appli
multipl increas ebitda excl dsc
paid result share price
downsid case would see lower aum growth driven
lower-than-forecast annual market appreci
slower-than-expect return posit flow failur
meet expens cut target appli multipl
declin ebitda excl dsc paid result
cad
embed commiss institut best interest
standard advisor chang equiti market materi
forecast annual growth return
consist posit retail net flow monet
agf interest smith
agf manag mid-siz mutual fund compani
canada mutual fund aum addit
institut sub-advisori hnw etf
altern aum agf fund sold third-parti
distributor agf also own smith
hold ltd provid invest legal tax
estat plan
bottom line organ growth stabl sequenti improv
transport steadi growth slight slow financi servic
manag outlin data strategi acceler product develop target
step-up long-term organ growth target view busi mix
well-posit cyclic upturn product demand auto
altern financi servic slightli rais estim maintain
outperform rate continu see strong long-term stori
organ growth mostli stabl annual organ growth stabl
result transport growth acceler slightli driven strong new product
pipelin auto busi resourc flat although subscript growth
remain steadi less wors financi servic growth slow
slow slightli mainli due tougher y/i comp inform busi
outlook reiter overal full-year guidanc across major segment
transport financi servic maintain although pace
margin expans temper second half due product invest
manag continu target step-up long-term organ revenu growth
data lake strategi manag provid updat strategi
auto busi integr organ data set allow
data combin access acceler compani product
solid outlook portfolio posit believ mix divers busi
well-posit whole name cyclic uptick continu
product rollout automot servic remain steadi upsid relat
altern space ipreo
slightli rais estim target price use revis
estim continu see strong long-term stori
lead inform servic exposur
automot financi servic end market
stabil energi market also support
ep share os
provis benefit inc tax
chang work capit
short long-term debt
growth margin data
averag price-to-earnings ev/ebitda discount cash flow base
forward-look estim
upsid assum multipl expans forward-look
ep estim higher
downsid assum multipl contract forward-
look ep estim lower
usd
new product cycl growth new market
world leader critic inform analyt
solut compani deliv next-gener
inform analyt solut custom
busi financ govern improv
oper effici provid deep insight lead
well-inform confid decis
takeaway ok quarter guidanc slightli
bottom line headlin slight ep miss read much
manag note continu growth across major product line
integr oasi acquisit decemb go well guidanc
incorpor prior consensu prior unoffici guidanc though quarterli
cadenc slightli reduc forward-look estim
take account expect slower start earnings-wis year
busi momentum continu headlin ep miss
result line expect manag highlight continu growth
across major product line specif comprehens outsourc retir
insur time attend solut
updat outlook similar prior initi look growth expect
moder mainli due impact slower insur busi larger
oasi peo busi grow lower rate margin expect
rel stabl y/i driven leverag base busi off-set addit
lower margin oasi busi
howev quarterli cadenc differ consensu guid adjust
ep growth growth expect rang
mainli impact amort integr cost relat oasi acquisit
decemb invest growth expect acceler
rang
reduc estim reflect slower expect start
growth solid though slow labor regul
overtim pay rule drive demand hr
servic industri churn rise creat opportun
share gain
ep share os
provis benefit inc tax
chang work capit
short long-term debt
growth margin data
averag price-to-earnings ev/ebitda discount cash flow base
forward-look estim
upsid assum multipl expans forward-look
ep estim higher
downsid assum multipl contract forward-
look ep estim lower
usd
payrol increas new busi format labor-
inc lead provid integr human
capit manag solut payrol hr retir
insur servic
fill blank
base inform ratio screen qualiti zuq remain best core
exposur investor addit low/minimum volatil canadian
defens exposur view supplementari qualiti identifi
dividend etf suitabl addit investor look equiti exposur
base return characterist track behaviour hold data dividend
etf fill gap qualiti low/minimum volatil risk/return
spectrum address investor concern zuq sector over-alloc
technolog commun servic
base screen follow etf remain best core exposur
investor
note hold zuq benchmark usa
qualiti still repres technolog commun
servic exposur index rebal last busi day may
 hedg trade highlight previous remain full swing
observ low/minimum volatil exposur diverg zuq
leav gap risk/return spectrum portfolio construct len
screen exposur abl fill blank qualiti
low/minimum volatil exposur
 look exposur demonstr posit activ return vs
 activ risk level qualiti exposur
low/minimum volatil exposur methodolog level
screen exposur may exhibit qualiti tilt found
follow dividend name fit profil rank activ return/
view etf provid exposur compani
sustain distribut and/or grow dividend supplement core
view dividend payers/grow screen supplement high
alloc technolog commun servic core qualiti
exposur also provid dividend incom backdrop
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
disclosur statement includ analyst certif pleas refer page
